Females Display Greater Disease Severity in a Mouse Model of Vitiligo
Pigment Cell & Melanoma Research · 2026-11 · 39 (6)
DOI: 10.1111/pcmr.70134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, online erschienen am 05.11.2026. Verfasst von Kaitlyn G O'Donnell und 12 weiteren Autor:innen. Beteiligte Einrichtung: Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Vitiligo. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Vitiligo is an autoimmune disease characterized by progressive depigmentation of the skin due to T cell‐mediated destruction of melanocytes. Disease onset varies but usually initiates during adolescence. Sex differences in disease development and therapeutic outcomes have not been explored. We previously associated stress induced HSP70i with immune activation in depigmentation and showed that HSP70i Q435A can tolerize dendritic cells (DCs) to prevent cutaneous recruitment and activation of T cells. Among male and female vitiligo‐prone mice, we investigated the long‐term efficacy of HSP70i Q435A plasmid DNA treatment introduced by biolistic administration at varying stages of vitiligo development. Mice were followed up to 46 weeks of age. Female mice exhibited 1.89‐fold greater depigmentation than males overall, while both responded proportionally to treatment with effects lasting throughout. This sex difference was associated with significantly elevated IFN‐γ secretion by melanocyte‐reactive T cells among female mice. Humoral responses to the protein remained readily detectable at end point regardless of treatment interval. These findings also suggest greater benefit from earlier intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Dermatology, Microbiology and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Department of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Department of Pediatrics, Lurie Children's Hospital, Northwestern University, Chicago, Illinois, USA.
ORCID-Profile: Kaitlyn G O'Donnell, Zhussipbek Mukhatayev, Rohan S Shivde, Octavio K Bartos, Ellis Kang, Emilia R Dellacecca, Dinesh Jaishankar, Ziyou Ren, I Caroline Le Poole
Förderung
- NIAMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
O'Donnell, K. G., Mukhatayev, Z., Abuzer, H., Shivde, R. S., Shanmugavelandy, S. S., Bartos, O. K., Kang, E., Dellacecca, E. R., Jaishankar, D., Pandey, S., Kang, H. K., Ren, Z., & Le Poole, I. C. (2026). Females Display Greater Disease Severity in a Mouse Model of Vitiligo. Pigment Cell & Melanoma Research, 39(6). https://doi.org/10.1111/pcmr.70134
Vancouver
O'Donnell KG, Mukhatayev Z, Abuzer H, Shivde RS, Shanmugavelandy SS, Bartos OK, et al. Females Display Greater Disease Severity in a Mouse Model of Vitiligo. Pigment Cell & Melanoma Research. 2026;39(6). doi:10.1111/pcmr.70134
BibTeX
@article{ODonnell2026,
author = {O'Donnell, Kaitlyn G and Mukhatayev, Zhussipbek and Abuzer, Hanin and Shivde, Rohan S and Shanmugavelandy, Sriram Saravanan and Bartos, Octavio K and Kang, Ellis and Dellacecca, Emilia R and Jaishankar, Dinesh and Pandey, Surya and Kang, Hee Kap and Ren, Ziyou and Le Poole, I Caroline},
title = {Females Display Greater Disease Severity in a Mouse Model of Vitiligo},
journal = {Pigment Cell & Melanoma Research},
year = {2026},
volume = {39},
number = {6},
doi = {10.1111/pcmr.70134}
}
EUVIMED